Cargando…

The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma

AIMS: To assess the additive effect of dorzolamide hydrochloride 2% on the diurnal intraocular pressure (IOP) curve and retrobulbar haemodynamics in patients with primary open-angle glaucoma (POAG) treated with morning-dosed bimatoprost 0.03%. METHODS: Twenty-five patients with POAG were evaluated i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stankiewicz, Andrzej, Wierzbowska, Joanna, Siemiątkowska, Anna, Fuksińska, Beata, Robaszkiewicz, Jacek, Zegadło, Arkadiusz, Ehrlich, Rita, Siesky, Brent, Harris, Alon
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2977936/ https://www.ncbi.nlm.nih.gov/pubmed/20558428 http://dx.doi.org/10.1136/bjo.2009.162859

Ejemplares similares

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial
por: Crichton, Andrew C, et al.
Publicado: (2014)

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
por: Day, Douglas G, et al.
Publicado: (2013)

A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
por: Jothi, R., et al.
Publicado: (2010)

A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension
por: Bell, Katharina, et al.
Publicado: (2022)

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
por: Merczel, Sára, et al.
Publicado: (2023)

Comparison of Intraocular Pressure, Blood Pressure, Ocular Perfusion Pressure and Blood Flow Fluctuations During Dorzolamide Versus Timolol Add-On Therapy in Prostaglandin Analogue Treated Glaucoma Subjects
por: Januleviciene, Ingrida, et al.
Publicado: (2012)

Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428]
por: Zeitz, Oliver, et al.
Publicado: (2005)

Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study
por: Chen, Ying Ying, et al.
Publicado: (2016)

Spheno-Orbital Meningioma and Vision Impairment—Case Report and Review of the Literature
por: Wierzbowska, Joanna, et al.
Publicado: (2022)

Triple therapy: Phaco-vitrectomy with ILM peeling, retinal endophotocoagulation, and intraoperative use of Bevacizumab for diffuse diabetic macular edema
por: Robaszkiewicz, Jacek, et al.
Publicado: (2012)

Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure
por: Lee, Susan S., et al.
Publicado: (2019)

The Effect of Diluted Penetration Enhancer in Nebulized Mist versus Liquid Drop Preparation Forms on Retrobulbar Blood Flow in Healthy Human Subjects
por: Primus, Sally, et al.
Publicado: (2012)

New Electrochemically-Modified Carbon Paste Inclusion β-Cyclodextrin and Carbon Nanotubes Sensors for Quantification of Dorzolamide Hydrochloride
por: Alarfaj, Nawal Ahmad, et al.
Publicado: (2016)

Bimatoprost in Dermatology
por: Jha, Abhijeet K., et al.
Publicado: (2018)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
por: Bell, Nicholas P, et al.
Publicado: (2010)

Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
por: García-López, Alfonso, et al.
Publicado: (2014)

Stereoselective Solvolysis in the Synthesis of Dorzolamide Intermediates
por: Martinelli, Andrea, et al.
Publicado: (2023)

Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film
por: Sedlak, Lech, et al.
Publicado: (2021)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Bimatoprost in the treatment of eyelash hypotrichosis
por: Law, Simon K
Publicado: (2010)

Bimatoprost Implant: First Approval
por: Shirley, Matt
Publicado: (2020)

Spontaneous Retrobulbar Haematoma
por: Deveer, Mehmet, et al.
Publicado: (2015)

Traumatic retrobulbar hemorrhage?
por: Manjandavida, Fairooz P, et al.
Publicado: (2018)

Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015)

Allergic contact dermatitis to dorzolamide and benzalkonium chloride
por: Orsini, Diego, et al.
Publicado: (2018)

Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant
por: Stamer, W. Daniel, et al.
Publicado: (2023)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
por: Smid, Scott D
Publicado: (2009)

Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy
por: Figurska, Małgorzata, et al.
Publicado: (2011)

Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma
por: Yeh, Jason, et al.
Publicado: (2008)

Management of hypotrichosis of the eyelashes: Focus on bimatoprost
por: Fagien, Steven
Publicado: (2010)

Correction to: Bimatoprost Implant: First Approval
por: Shirley, Matt
Publicado: (2020)

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% — an observational switch study
por: Deshpande, Sarita S, et al.
Publicado: (2017)

Effect of dorzolamide/timolol combination on the visual field in glaucoma
por: Takeda, Sakurako, et al.
Publicado: (2014)

Dramatic response to topical dorzolamide in X-linked retinoschisis
por: Thangavel, Rajeswari, et al.
Publicado: (2020)

Retrobulbar Optic Nerve Cysticercosis
por: Narra, Ramakrishna, et al.
Publicado: (2015)

Retrobulbar chondrosarcoma in a dog
por: Ralić, M., et al.
Publicado: (2014)

Optic Neuritis (Retrobulbar and Papillary)
por: Paton, Leslie
Publicado: (1937)

Fixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timolol
por: Fang, Yuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3atgeqkpcakqppmosg2d9e617b